Home > Healthcare > Biotechnology > Biotechnology R&D > Cloning and Mutagenesis Market
Cloning and Mutagenesis Market valued at USD 2.9 billion in 2023 and is expected to expand at over 19.4% CAGR between 2024 and 2032. Growing focus on genetic engineering and rising demand for genetically modified products is escalating the growth prospects for the market. Cloning and mutagenesis technologies play a crucial role in the development of precision medicine. Hence, increasing demand for precision medicine has a significant influence on the market demand.
Furthermore, rising investments and funding from both public and private sectors, government initiatives, venture capital funding, and collaborations between academic institutions and industry players have fuelled technological advancements and product innovation, thereby positively influencing cloning and mutagenesis market growth.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Cloning and Mutagenesis Market Size in 2023: | USD 2.9 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 19.4% |
2032 Value Projection: | USD 14.6 Billion |
Historical Data for: | 2018 – 2023 |
No. of Pages: | 120 |
Tables, Charts & Figures: | 210 |
Segments covered: | Product, Technology, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Cloning refers to the creation of identical copies of a particular DNA sequence. In molecular biology, cloning is commonly used to replicate genes or DNA fragments for further analysis or manipulation. Whereas mutagenesis is a technique in which the DNA of an organism is altered or changed, which results in the mutation of the genes. Cloning and mutagenesis methods are used to confirm the mutation effects in vitro and in vivo and study the structure and function of proteins.